drugset / Trial / NCT04225078

A Study to Evaluate the Effects of Loperamide (JNJ-289679) on Electrocardiogram Intervals in Healthy Adult Participants

NCT04225078

Phase 1 Completed 66 enrolled Janssen Research & Development, LLC
RandomizedCrossoverQuadruple-blindDiagnostic

Summary

The purpose of this study is to assess the effects of loperamide on QT/ QT interval corrected for heart rate (QTc) intervals and electrocardiogram (ECG) morphology at therapeutic and supratherapeutic exposures in healthy participants.

Timeline

Start
2020-01-17
Primary completion
2021-12-21
Completion
2022-01-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Loperamide Small molecule Oral
Subject Moxifloxacin Small molecule Oral

Indications

No indication recorded.